ARCHIVES

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Reviewed CCOP Applications Won’t Be Funded; Potter Recruiting For New Medical Oncology Chief

September 30, 1983

NCAB Seeks Exemption From New Reimbursement Plan For Clinical Trials, Modification Of Hospice Regs

February 11, 1983

HRT Doesn’t Raise Cancer Risk Following Oophorectomy

October 28, 2005

Larry Norton wins ASCO’s Karnofsky award.

May 28, 2004

Fibrolast Interferon Contract Signed

May 2, 1980

ODAC Calls For Tougher Standards For Accelerated Approval In Oncology

February 11, 2011